MedPath

Traditional Chinese medicine formulation combined with promestriene in the treatment of genitourinary syndrome of menopause (GSM) : a randomized, double-blind, controlled clinical trial

Phase 1
Not yet recruiting
Conditions
genitourinary syndrome of menopause, GSM
Registration Number
ITMCTR2000003596
Lead Sponsor
International Peace Maternity & Child Health Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

1.2 inclusion criteria
1.2.1 the postmenopausal women meeting the GSM diagnostic criteria and age over 40 years old
1.2.2 the people of no use of hormonal drugs at least 3 months
1.2.3 the people volunteered for the experiment, and signed the informed consent

Exclusion Criteria

1.3 exclusion standard
1.3.1the people without sexual partners because of unmarried, divorced, widowed and other reasons
1.3.2 the people who use GnRH - a or steroid hormone in three months
1.3.3 the people who place levonorgestrel intrauterine sustained release system into uterus
1.3.4 the people who have severe disease about heart and cerebral vessels or liver or kidney or diabetes or malignant tumor or the others.
1.3.5 the people who affect cognition on account of mental disorder or medicine or chronic drinking
1.3.6 the people who have coagulation dysfunction or thrombotic disease
1.3.7 the people who participate in other drug clinical trials

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.